Literature DB >> 30306833

Joint modeling of multiple repeated measures and survival data using multidimensional latent trait linear mixed model.

Jue Wang1, Sheng Luo2.   

Abstract

Impairment caused by Amyotrophic lateral sclerosis (ALS) is multidimensional (e.g. bulbar, fine motor, gross motor) and progressive. Its multidimensional nature precludes a single outcome to measure disease progression. Clinical trials of ALS use multiple longitudinal outcomes to assess the treatment effects on overall improvement. A terminal event such as death or dropout can stop the follow-up process. Moreover, the time to the terminal event may be dependent on the multivariate longitudinal measurements. In this article, we develop a joint model consisting of a multidimensional latent trait linear mixed model (MLTLMM) for the multiple longitudinal outcomes, and a proportional hazards model with piecewise constant baseline hazard for the event time data. Shared random effects are used to link together two models. The model inference is conducted using a Bayesian framework via Markov chain Monte Carlo simulation implemented in Stan language. Our proposed model is evaluated by simulation studies and is applied to the Ceftriaxone study, a motivating clinical trial assessing the effect of ceftriaxone on ALS patients.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Markov chain Monte Carlo; informative dropout; longitudinal data; mixed model

Mesh:

Substances:

Year:  2018        PMID: 30306833      PMCID: PMC6478574          DOI: 10.1177/0962280218802300

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  21 in total

1.  Joint modelling of longitudinal measurements and event time data.

Authors:  R Henderson; P Diggle; A Dobson
Journal:  Biostatistics       Date:  2000-12       Impact factor: 5.899

2.  Which individuals make dropout informative?

Authors:  Ronald B Geskus
Journal:  Stat Methods Med Res       Date:  2012-04-25       Impact factor: 3.021

3.  The use of raw scores from ordinal scales: time to end malpractice?

Authors:  Gunnar Grimby; Alan Tennant; Luigi Tesio
Journal:  J Rehabil Med       Date:  2012-02       Impact factor: 2.912

4.  Assessing individual quality of life in amyotrophic lateral sclerosis.

Authors:  S Clarke; A Hickey; C O'Boyle; O Hardiman
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

5.  Dynamic predictions and prospective accuracy in joint models for longitudinal and time-to-event data.

Authors:  Dimitris Rizopoulos
Journal:  Biometrics       Date:  2011-02-09       Impact factor: 2.571

6.  Gaining precision on the Alzheimer's Disease Assessment Scale-cognitive: a comparison of item response theory-based scores and total scores.

Authors:  Steve Balsis; Alexis A Unger; Jared F Benge; Lisa Geraci; Rachelle S Doody
Journal:  Alzheimers Dement       Date:  2012-03-30       Impact factor: 21.566

7.  ASSESSING THE ASSOCIATION BETWEEN TRENDS IN A BIOMARKER AND RISK OF EVENT WITH AN APPLICATION IN PEDIATRIC HIV/AIDS.

Authors:  Elizabeth R Brown
Journal:  Ann Appl Stat       Date:  2009-09-01       Impact factor: 2.083

8.  The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation.

Authors:  Daniele Lo Coco; Santino Marchese; Vincenzo La Bella; Tommaso Piccoli; Albino Lo Coco
Journal:  Chest       Date:  2007-05-02       Impact factor: 9.410

9.  Analysis of longitudinal randomized clinical trials using item response models.

Authors:  Cees A W Glas; Hanneke Geerlings; Mart A F J van de Laar; Erik Taal
Journal:  Contemp Clin Trials       Date:  2008-12-24       Impact factor: 2.226

Review 10.  Amyotrophic lateral sclerosis.

Authors:  Lokesh C Wijesekera; P Nigel Leigh
Journal:  Orphanet J Rare Dis       Date:  2009-02-03       Impact factor: 4.123

View more
  1 in total

1.  Bayesian joint modelling of longitudinal and time to event data: a methodological review.

Authors:  Maha Alsefri; Maria Sudell; Marta García-Fiñana; Ruwanthi Kolamunnage-Dona
Journal:  BMC Med Res Methodol       Date:  2020-04-26       Impact factor: 4.615

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.